Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

University of Arizona

5 clinical trials · 5 recruiting · OTHER

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

Trials by University of Arizona

RECRUITINGPhase 2NCT05676255

The Breast Cancer Survivors and Partners Online Research Together (SUPORT) Project

Many breast cancer survivors (estimated 70% in some studies) experience clinically significant depression and/or anxiety in the months and years after finishing cancer treatments....

Sponsor: University of ArizonaEnrolling: 4521 location
Breast Cancer FemalePsychological Distress
RECRUITINGPhase 1 / Phase 2NCT06282965

Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury

The goal of this clinical trial is to test the safety of the drug Angiotensin (1-7) and learn whether it works well as a treatment in people who have suffered a moderate to severe...

Sponsor: University of ArizonaEnrolling: 901 location
Traumatic Brain Injury
RECRUITINGPhase 3NCT04062565

Trial to Evaluate Parenteral Treprostinil and Riociguat on Right Ventriculo-vascular Coupling and Morphology in Those...

The purpose of this study is to determine if there is a greater effect to patients with advanced pulmonary arterial hypertension (PAH) by using a combination of two drugs,...

Sponsor: University of ArizonaEnrolling: 201 location
Pulmonary Arterial Hypertension
RECRUITINGNCT04725617

Wellness Intervention for Smoking and HIV

The investigators propose to use a parallel group, randomized controlled trial to test the efficacy of a 13-week personalized approach to reducing smoking intervention versus a...

Sponsor: University of ArizonaEnrolling: 2002 locations
HIVSleepSmoking Cessation+1
RECRUITINGPhase 1 / Phase 2NCT06814496

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

Phase I study to examine safety of the addition of concurrent tarlatamab with standard palliative and consolidative RT regimens , with a main cohort of N=20-24 patients with...

Sponsor: University of ArizonaEnrolling: 301 location
MelanomaMedullary Thyroid CancerSinonasal Undifferentiated Carcinoma+8